Scary that Alpharma/King were marketing the unstable dose dumping Embeda starting in Fall 2009. Pfizer bought Alpharma/King a year later in 2010. Pfizer committed a major accountant analysis blunder as they failed to study the obvious Science, Manufacturing, Patent infringements, and Legal woes. Pfizer Embeda was withdrawn in 2011 and remained withdrawn for 4 years until Feb 2015.